These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25867647)

  • 1. High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.
    Reljic T; Kumar A; Djulbegovic B; Kharfan-Dabaja MA
    Bone Marrow Transplant; 2015 Aug; 50(8):1069-74. PubMed ID: 25867647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis.
    El-Asmar J; Reljic T; Ayala E; Hamadani M; Nishihori T; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2016 May; 22(5):802-14. PubMed ID: 26713431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis.
    Epperla N; Reljic T; Chowdhury SM; Ferreri AJM; Kumar A; Hamadani M
    Hematol Oncol; 2023 Feb; 41(1):88-96. PubMed ID: 36192141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.
    Koreth J; Cutler CS; Djulbegovic B; Behl R; Schlossman RL; Munshi NC; Richardson PG; Anderson KC; Soiffer RJ; Alyea EP
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):183-96. PubMed ID: 17241924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?
    Epperla N; Fenske TS; Lazarus HM; Hamadani M
    Bone Marrow Transplant; 2015 Nov; 50(11):1393-404. PubMed ID: 26281033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials.
    Chakraborty R; Siddiqi R; Willson G; Gupta S; Asghar N; Husnain M; Aljama MA; Behera TR; Anwer F; Perrot A; Riaz IB
    Cancer; 2022 Jun; 128(12):2288-2297. PubMed ID: 35377484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
    Iqbal M; Reljic T; Klocksieben F; Sher T; Ayala E; Murthy H; Bazarbachi A; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1695-1700. PubMed ID: 31132453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.
    Kharfan-Dabaja MA; Hamadani M; Reljic T; Nishihori T; Bensinger W; Djulbegovic B; Kumar A
    J Hematol Oncol; 2013 Jan; 6():2. PubMed ID: 23289975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation.
    Epperla N; Badar T; Szabo A; Vaughn J; Borson S; Saini NY; Patel RD; Shah NN; Hamadani M; Ahmed S; Cashen AF; Fenske TS
    Blood Adv; 2019 Jun; 3(11):1661-1669. PubMed ID: 31167818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study.
    Kharfan-Dabaja MA; Raj R; Nikolaenko L; Ahmed S; Reddy N; Nathan S; Cherry M; El-Jurdi N; Obiozor C; Fenske TS; Song J; Muzzafar T; Ayala E; Savani B; Khawandanah M; Caimi PF; Hamadani M; Forman SJ; Hussaini M; de Lima M; Olteanu H; Shah B; Chavez JC; Al Malki M; Kumar A; Ganguly S
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):486-493. PubMed ID: 29225164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia.
    Jindra P; Raida L; Lysak D; Karas M; Papajik T; Jungova A; Mohammadová L; Houdova L
    Neoplasma; 2016; 63(4):595-600. PubMed ID: 27268923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial.
    Brion A; Mahé B; Kolb B; Audhuy B; Colombat P; Maisonneuve H; Foussard C; Bureau A; Ferrand C; Lesesve JF; Béné MC; Feugier P;
    Bone Marrow Transplant; 2012 Apr; 47(4):542-8. PubMed ID: 21725374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
    Kharfan-Dabaja MA; Kumar A; Behera M; Djulbegovic B
    Br J Haematol; 2007 Oct; 139(2):234-42. PubMed ID: 17897299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma: myeloablative therapy with autologous stem cell support versus chemotherapy: a meta-analysis.
    Faussner F; Dempke WC
    Anticancer Res; 2012 May; 32(5):2103-9. PubMed ID: 22593496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autologous hematopoietic stem cell transplantation in multiple myeloma.
    Harousseau JL; Attal M
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):61-6. PubMed ID: 9122747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.
    Drabko K; Raciborska A; Bilska K; Styczynski J; Ussowicz M; Choma M; Wojcik B; Zaucha-Prazmo A; Gorczynska E; Skoczen S; Wozniak W; Chybicka A; Wysocki M; Gozdzik J; Kowalczyk J
    Bone Marrow Transplant; 2012 Dec; 47(12):1530-4. PubMed ID: 22609883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
    Dreger P; Michallet M; Schmitz N
    Ann Oncol; 2000; 11 Suppl 1():49-53. PubMed ID: 10707779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.